Immune Modulation Therapy - Peripheral Vascular Disease - Vasogen: (VasoCare)

Author：

ISSN： 1174-5886

Source： Drugs in R&D, Vol.3, Iss.5, 2002-01, pp. : 358-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological revascularisation in coronary and peripheral vascular disease

By Tarzami Sima T Singh Jai Pal

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 10, 2004-10 ,pp. : 1319-1326

Informa Healthcare

Access to resources Recommend Favorite

Screening for peripheral arterial disease in primary care

Inpharma, Vol. 1, Iss. 1307, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Gene therapy for coronary and peripheral artery disease

By Nikol Sigrid

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 8, 2008-08 ,pp. : 903-927

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy-Mediated Modulation of Immune Processes in the Central Nervous System

Current Pharmaceutical Design, Vol. 9, Iss. 24, 2003-09 ,pp. : 2002-2008

Bentham Science Publishers

Access to resources Recommend Favorite

Cytostatic gene therapy for occlusive vascular disease

By González José M Andrés Vicente

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 507-522

Informa Healthcare

Access to resources Recommend Favorite